An observational study in Type 1 Diabetes Mellitus, sponsored by Assiut University. Not yet recruiting. Open to participants aged 1 Year to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.
Sponsored by Assiut University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Diabetes Mellitus, Type 1 by Assiut University — 7 open to participants now, 7 under way, none of them phase 3. Diabetes Mellitus, Type 1 · Assiut University.
Among the 11 studies in Diabetes Mellitus, Type 1 by Assiut University, this one has the largest planned enrollment of the 10 observational ones that give a count, is one of 3 that started in 2026, is one of 10 observational ones, and was the 11th registered.
3,758 studies on the registry are indexed under Diabetes Mellitus, Type 1; 600 are open to participants now.
Browse Diabetes Mellitus, Type 1 studies →7 of the 11 studies in Diabetes Mellitus, Type 1 by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University · Sites in Egypt
Ages up to 18 · Healthy volunteers
Assiut University
Ages 18–80
Assiut University
Ages 1–18
Assiut University
Ages 2–18
Assiut University
Ages 8–15
By country, each count listing its studies:
Of the 417 Diabetes Mellitus, Type 1 studies recruiting now, 130 (31%) set no upper age limit and 261 (63%) stop at 75 or younger; 187 take children under 18; 66 take healthy volunteers.
This study: 1 Year to 18 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 254 is above the median of 125 across 791 observational studies indexed under Diabetes Mellitus, Type 1.
Median enrollment 100 across the 1 interventional studies, 115 across the 10 observational. None of them has completed or been terminated yet.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Diabetes Mellitus, Type 1 by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07845175Assiut UniversityGastrointestinal Symptoms in Children With Type 1 Diabetes | 2027-09-26 |
| NCT07476248Assiut UniversityThe Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus | 2027-10-01 |
| NCT07807553Assiut UniversityLiver Function Test Abnormalities in Pediatric Type 1 Diabetes | 2027-10-02 |
Add all 3 to your calendar (.ics) → With an account.
Among the 11 studies in Diabetes Mellitus, Type 1 by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This cross-sectional study aims to assess the frequency and types of gastrointestinal symptoms in children with type 1 diabetes mellitus compared with age- and sex-matched healthy controls.
Gastrointestinal symptoms are relatively common among children with type 1 diabetes mellitus and may affect nutritional status and glycemic control. This observational study will include children aged 1 to 18 years with type 1 diabetes mellitus and age- and sex-matched healthy controls.
Participants will be assessed for the presence and types of gastrointestinal symptoms using a structured history and clinical examination.
Children and adolescents aged 1-18 years with type 1 diabetes mellitus attending Assiut University Children's Hospital, and age- and sex-matched healthy controls.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children with type 1 diabetes mellitus who will be assessed for gastrointestinal symptoms.
Age- and sex-matched healthy children without diabetes who will undergo the same symptom assessment.
Prevalence of gastrointestinal symptoms
Proportion of children with at least one gastrointestinal symptom in the type 1 diabetes group compared with healthy controls.
Time frame: Baseline
Prevalence of abdominal pain
Proportion of children reporting abdominal pain.
Time frame: Baseline
Prevalence of nausea
Proportion of children reporting nausea.
Time frame: Baseline
Prevalence of vomiting
Proportion of children reporting vomiting.
Time frame: Baseline
Prevalence of constipation
Proportion of children reporting constipation.
Time frame: Baseline
Prevalence of diarrhea
Proportion of children reporting diarrhea.
Time frame: Baseline
Prevalence of bloating
Proportion of children reporting bloating.
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Sep 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.